MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines

被引:67
作者
Hummel, Richard [1 ,2 ]
Sie, Corina [1 ]
Watson, David I. [1 ]
Wang, Tingting [1 ]
Ansar, Alfiya [1 ]
Michael, Michael Z. [3 ]
Van der Hoek, Mark [4 ]
Haier, Joerg [5 ]
Hussey, Damian J. [1 ]
机构
[1] Flinders Univ S Australia, Med Ctr, Dept Surg, Bedford Pk, SA 5042, Australia
[2] Univ Munster, Dept Gen & Visceral Surg, D-48149 Munster, Germany
[3] Flinders Univ S Australia, Dept Gastroenterol & Hepatol, Bedford Pk, SA 5042, Australia
[4] Adelaide Microarray Ctr, SA Pathol, Adelaide, SA 5000, Australia
[5] Univ Munster, Ctr Comprehens Canc, D-48149 Munster, Germany
基金
英国医学研究理事会;
关键词
Esophageal cancer; MicroRNA; Chemotherapy; Resistance; Target; MULTIDRUG-RESISTANCE; CONFERS RESISTANCE; CARCINOMA; CHEMORADIOTHERAPY; METAANALYSIS; SURVIVAL; RECEPTOR;
D O I
10.3748/wjg.v20.i40.14904
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate expression of microRNA (miRNA) and potential targets in chemotherapy resistant esophageal cancer cell lines. METHODS: An in-vitro model of acquired chemotherapy resistance in esophageal adeno- (EAC) and squamous cell carcinoma (ESCC) cells was used, and microRNA expression profiles for cisplatin or 5-fluorouracil (5-FU) resistant variants vs chemotherapy sensitive controls were compared using microarray and quantitative real-time polymerase chain reaction (PCR). The expression of chemotherapy-relevant genes potentially targeted by the dysregulated microRNAs in the chemotherapy resistant variants was also evaluated. RESULTS: Chemotherapy resistant sublines were found to have specific miRNA signatures, and these miRNA signatures were different for the cisplatin vs 5-FU resistant cells from the same tumor cell line, and also for EAC vs ESCC cells with resistance to the same specific chemotherapy agent. Amongst others, miR-27b-3p, miR-193b-3p, miR-192-5p, miR-378 a-3p, miR-125a-5p and miR-18a-3p were dysregulated, consistent with negative posttranscriptional control of KRAS, TYMS, ABCC3, CBL-B and ERBB2 expression via these miRNAs. CONCLUSION: The current study supports the hypothesis that microRNA expression has an impact on chemotherapy resistance in esophageal cancer. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:14904 / 14912
页数:9
相关论文
共 28 条
[1]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[2]   miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation [J].
Boni, Valentina ;
Bitarte, Nerea ;
Cristobal, Ion ;
Zarate, Ruth ;
Rodriguez, Javier ;
Maiello, Evaristo ;
Garcia-Foncillas, Jesus ;
Bandres, Eva .
MOLECULAR CANCER THERAPEUTICS, 2010, 9 (08) :2265-2275
[3]   Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3 [J].
Chen, XM ;
Yeung, TK ;
Wang, ZX .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 277 (03) :757-763
[4]   Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer [J].
Davids, Matthew S. ;
Letai, Anthony .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) :3127-3135
[5]   Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa [J].
de Bruijn, M. T. ;
Raats, D. A. E. ;
Hoogwater, F. J. H. ;
van Houdt, W. J. ;
Cameron, K. ;
Medema, J. P. ;
Rinkes, I. H. M. Borel ;
Kranenburg, O. .
BRITISH JOURNAL OF CANCER, 2010, 102 (08) :1254-1264
[6]   MicroRNA and its roles in esophageal cancer [J].
Fang, Yu ;
Fang, Dianchun ;
Hu, Jianguo .
MEDICAL SCIENCE MONITOR, 2012, 18 (03) :RA22-RA30
[7]   Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis [J].
Gebski, Val ;
Burmeister, Bryan ;
Smithers, B. Mark ;
Foo, Kerwyn ;
Zalcberg, John ;
Simes, John .
LANCET ONCOLOGY, 2007, 8 (03) :226-234
[8]   Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway [J].
Hamano, Rie ;
Miyata, Hiroshi ;
Yamasaki, Makoto ;
Kurokawa, Yukinori ;
Hara, Johji ;
Moon, Jeong Ho ;
Nakajima, Kiyokazu ;
Takiguchi, Shuji ;
Fujiwara, Yoshiyuki ;
Mori, Masaki ;
Doki, Yuichiro .
CLINICAL CANCER RESEARCH, 2011, 17 (09) :3029-3038
[9]   MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell Carcinoma [J].
Hiyoshi, Yukiharu ;
Kamohara, Hidenobu ;
Karashima, Ryuichi ;
Sato, Nobutaka ;
Imamura, Yu ;
Nagai, Youhei ;
Yoshida, Naoya ;
Toyama, Eiichiro ;
Hayashi, Naoko ;
Watanabe, Masayuki ;
Baba, Hideo .
CLINICAL CANCER RESEARCH, 2009, 15 (06) :1915-1922
[10]   The Prognostic and Chemotherapeutic Value of miR-296 in Esophageal Squamous Cell Carcinoma [J].
Hong, Liu ;
Han, Yu ;
Zhang, Hongwei ;
Li, Mengbin ;
Gong, Taiqian ;
Sun, Li ;
Wu, Kaichun ;
Zhao, Qingchuan ;
Fan, Daiming .
ANNALS OF SURGERY, 2010, 251 (06) :1056-1063